The Prevention and Treatment of Endometrial Pathology in Postmenopausal Women receiving Exogenous Estrogens

  • J. W. W. Studd
  • M. H. Thom
  • M. E. L. Paterson
  • T. Wade-Evans
Chapter

Abstract

Most gynecologists will now accept that approximately 25% of women of menopausal age would be sufficiently distressed by symptoms of estrogen deficiency to warrant specific estrogen therapy proven to be of benefit by many trials1–3. More recently, Hammond et al. 4 have demonstrated that replacement estrogen therapy has longterm metabolic benefits in significantly reducing the incidence of strokes, heart attacks, hypertension, osteoporosis and fractures. However, there is a widespread fear that this treatment will result in an increased incidence of endometrial carcinoma, although until 5 years ago it was generally believed that there was no such risk. There are now many case-controlled studies from the United States5–9 showing between a five-fold and 15-fold increased risk of cancer of the uterus in these patients. This risk is both duration-dependent and dose-dependent.

Keywords

Endometrial Cancer Endometrial Carcinoma Estrogen Therapy Atypical Hyperplasia Endometrial Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Utian, W. H. (1972). The true features of the post-menopause and oophorectomy and their response to oestrogen therapy. S. Afr. Med. J., 46, 732PubMedGoogle Scholar
  2. 2.
    Campbell, S. and Whitehead, M. L. (1977). In R. B. Greenblatt and J. W. W. Studd (eds), Clinics in Obstetrics and Gynaecology, 4, 31–47. (London: Saunders)Google Scholar
  3. 3.
    Studd, J., Chakravarti, S. and Oram, D. (1977). In R. B. Greenblatt and J. W. W. Studd (eds), Clinics in Obstetrics and Gynaecology, 4, 3–29. (London: Saunders)Google Scholar
  4. 4.
    Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T. and Parker, R. T. (. 1977 ). Effects of long-term estrogen replacement therapy. Am. J. Obstet. Gynecol., 133, 525Google Scholar
  5. 5.
    Smith, D. G., Prentice, R. and Thompson, D. J. (1975). Association of exogenous estrogens and endometrial carcinoma. N. Engl. J. Med., 293, 1164PubMedCrossRefGoogle Scholar
  6. 6.
    Zeil, H. K. and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med., 293, 1167CrossRefGoogle Scholar
  7. 7.
    Mack, T. M., Pike, M. C., Henderson, B. E., Pfeffer, R. I., Gerkins, V. R., Arthur, M. and Brown, S. E. (1976). Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med., 294, 1262PubMedCrossRefGoogle Scholar
  8. 8.
    Antunes, C. M. F., Stolley, P. D., Rosenheim, N. B., Davies, J. L., Tonascia, J. A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M. and Garcia, R. (1979). Endometrial cancer and estrogen use. N. Eng!. J. Med., 300, 1 CrossRefGoogle Scholar
  9. 9.
    Jick, H., Watkins, R. N., Hunter, J. R., Dinen, B. J., Madsen, S., Rothmark, J. and Waiter, A. M. (1979). Replacement estrogens and endometrial carcinoma. N. Engl. J. Med., 300, 218PubMedCrossRefGoogle Scholar
  10. 10.
    Studd, J. W. W. and Thom, M. H. (1979). Estrogen use and endometrial cancer. N. Eng!. J. Med., 300, 922Google Scholar
  11. 11.
    Horwitz, R. I. and Feinstein, A. R. (1978). Alternative analytic methods for case control studies of estrogens and endometrial cancer. N. Eng!. J. Med., 299, 1089CrossRefGoogle Scholar
  12. 12.
    Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T. and Parker, R. T. (1979). The effects of long-term estrogen replacement therapy. II. Neoplasia. Am. J. Obstet. Gynecol., 133, 537PubMedGoogle Scholar
  13. 13.
    Gusberg, S. B. (1947). Precursors of corpus carcinoma. Estrogen and adenomatous hyperplasia. Am. J. Obstet. Gynecol., 54, 904Google Scholar
  14. 14.
    Welch, W. R. and Scully, R. E. (1977). Pre-cancerous lesions of the endometrium. Hum. Pathol., 8 (5), 503PubMedCrossRefGoogle Scholar
  15. 15.
    Gusberg, S. B. and Kaplan, A. L. (1963). Precursors of corpus cancer. IV. Adenomatous hyperplasia as Stage 0 carcinoma of the endometrium. Am. J. Obstet. Gynecol., 87, 662PubMedGoogle Scholar
  16. 16.
    Hertig, A. T., Sommers, S. C. and Bengloft, H. (1949). Genesis of endometrial carcinoma. IlI. Carcinoma in situ. Cancer, 2, 964Google Scholar
  17. 17.
    Sturdee, D. W., Wade-Evans, T., Paterson, M. E. L., Thom, M. H. and Studd, J. W. W. (1978). Relations between bleeding pattern, endometrial histology and oestrogen treatment in menopausal women. Br. Med. J., 1, 1575PubMedCrossRefGoogle Scholar
  18. 18.
    Campbell, S., McQueen, J., Minardi, J. and Whitehead, M. I. (1978). The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens. Postgrad. Med. J., 54 (Suppl. 2), 59PubMedGoogle Scholar
  19. 19.
    Patterson, M. E. L., Sturdee, D. W., Wade-Evans, T., Thom, M. H. and Studd, J. W. W. (1979). (In preparation)Google Scholar
  20. 20.
    Thom, M. H., White, P. J., Williams, R. M., Paterson, M. E. L., Wade-Evans, T. and Studd, J. W. W. (1979). The prevention and treatment of endometrial lesions in women on oestrogen therapy for climacteric symptoms. Lancet, 2, 455PubMedCrossRefGoogle Scholar
  21. 21.
    Oestergaard, E. (1974). Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in post-menopausal women treated with oestrogen. Acta Obstet. Gynecol. Scand., 53, 97CrossRefGoogle Scholar
  22. 22.
    Ferenczy, A. and Richart, T. M. (1973). Scanning and transmission electron microscopy of the human endometrial surface epithelium. J. Clin. Endocrinol. Metab., 36, 999PubMedCrossRefGoogle Scholar
  23. 23.
    Ferenczy, A. and Richart, R. M. (1973). Scanning electron microscopy of hyperplastic and neoplastic endometria. In O. Johan (ed.), Scanning Electron Microscopy 1973, Part III. Proceedings of the Workshop on SEM in Pathology, pp. 613–20. ( Chicago: IIT Research Institute )Google Scholar
  24. 24.
    Nilsson, O., Kottmeir, H. L. and Tillinger, K. G. (1963). Some differences in the ultra-structure of normal and cancerous human uterine endometrium. Acta Obstet. Gynecol. Scand., 45, 73CrossRefGoogle Scholar
  25. 25.
    Greenblatt, R. B. (1965). Estrogen therapy for postmenopausal females. N. Engl. J. Med., 272, 305PubMedCrossRefGoogle Scholar
  26. 26.
    Gambrell, R. D. Jr. (1974). Perimenopausal and postmenopausal bleeding: mechanisms, pathology, management with progestational agents. In R. B. Greenblatt, V. B. Mahesh and P. G. McDonough), The Menopausal Syndrome, pp. 147–56. ( New York: Medcam Press )Google Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • J. W. W. Studd
  • M. H. Thom
  • M. E. L. Paterson
  • T. Wade-Evans

There are no affiliations available

Personalised recommendations